Last week, we had the privilege of participating in the #Innovation_Managers_Forum at Ichilov Tech. It was an insightful session with Dr. Gilad Lehmann discussing innovation in the treatment of aging and Rivka Zaibel from ADRES addressing regulatory aspects in drug development. Our Managing Partner and CEO of Peregrine’s incubator, Lior Shahory, shared valuable insights drawn from his extensive experience in healthcare ventures. He spoke about recognizing true medical needs, selecting the right focus areas, and how to evaluate when an idea has a strong potential to become a successful company. Lior also highlighted the key factors for building a successful medical enterprise, including how to effectively structure a financing plan, supported by case studies from his extensive career. Thank you, Yael Arusi and Benjamin Soffer, for inviting us and creating such an engaging platform for sharing ideas and insights!
Peregrine Ventures’ Post
More Relevant Posts
-
Verve Ventures was recently featured among the top techbio and drug discovery investors in Dealroom.co and Speedinvest's TechBio x Drug Discovery report which explores the vast potential of innovation in this field. “We believe that startups embracing the convergence of biology and engineering have the power to shape a future where healthcare is not only more cost-effective but also delivers superior patient outcomes,” says Xavier Mesnier, Principal at Verve. “Through AI-driven patient profiling, platform technologies, and enabling tools, techbio entrepreneurs are catalyzing a paradigm shift in healthcare, where data-driven insights revolutionize how we understand and combat disease." Read the full report: https://lnkd.in/d9BcvV2Q #techbio #drugdiscovery #health #drugdevelopment #futureofhealth #venturecapital
To view or add a comment, sign in
-
🌟 We’re Launching in SoCal! Transforming the Future of Medical Innovation 🌟 We’re thrilled to announce the launch of our presence in the vibrant Southern California medical ecosystem! Focused on medical devices and biotech startups, we’re here to empower groundbreaking innovations from seed and angel stages through to Series A funding. Through the Medical Reformation FUND™ and the powerful ECOSYS™ network, we’re not just offering financial support—we’re providing a comprehensive ecosystem designed to significantly boost success rates. Our approach integrates: ✅ Strategic Investments tailored to each project’s unique potential. ✅ Expert Guidance in regulatory pathways, R&D, and production. ✅ Scalable Infrastructure to accelerate development and market entry. ✅ Targeted Market Insights to ensure products align with real-world needs. With FUND™ + ECOSYS™, we create a BIG difference by enabling startups to overcome challenges, fast-track progress, and increase their likelihood of success. Together, we’re shaping the future of healthcare by bringing innovative solutions to life. If you’re in medical devices or biotech and ready to revolutionize the industry, let’s connect! 🌐 #MedicalReformation #FUNDandECOSYS #SoCalInnovation #BiotechStartups #MedicalDevices #SeedtoSeriesA
To view or add a comment, sign in
-
At Motitus, we believe Digital Transformation is not just about technology — it's about empowering people and fostering innovation. Our Product Suite is designed to unlock new possibilities for businesses in the healthcare sector. Join us on this journey! Whether you're a startup looking to make your mark or an established organization aiming to innovate, we have the tools to help you succeed. Let's connect, collaborate, and create impactful solutions together. Why Choose Motitus? Holistic Approach: Our Product Suite offers end-to-end support for your digital transformation efforts, ensuring that all aspects of your business are aligned with your innovation goals. Expert Guidance: With our extensive network of industry experts and mentors, you can navigate the complexities of digital transformation with confidence. Enhanced Collaboration: We promote a culture of collaboration among startups, investors, and established companies, driving innovation and growth within the healthcare sector. www.motitus.com 💬 I’d love to hear your thoughts: What challenges are you facing in your digital transformation journey? #Biotechnology #Pharmaceuticals #Healthcare #HealthTech #Motitus #Consulting #BusinessConsulting https://lnkd.in/d5tnV-ax https://lnkd.in/dBwcsA29
Digital transformation is no longer just a trend; it's necessary for businesses aiming to thrive in today's fast-paced environment. At Motitus, we understand the challenges and opportunities that come with this shift, and our Product Suite is designed to guide your organization through every step of the journey. How Motitus Can Propel Your Business Forward CubinQ: Our health tech startup accelerator, CubinQ is dedicated to fostering innovation within digital health ventures. Our comprehensive support program connects startups with key stakeholders in the healthcare ecosystem, nurturing a community of innovators, researchers, and healthcare providers. By facilitating collaboration, CubinQ helps tackle significant challenges such as data management and digital therapeutics, ultimately accelerating the market introduction of groundbreaking healthcare solutions. MedratiO: Our cutting-edge platform leverages advanced system dynamics simulations to provide healthcare professionals and managers with insights into complex healthcare challenges. MedratiO empowers organizations to make informed decisions and operational efficiency, ensuring that your business remains at the forefront of healthcare innovation. AtraDeus: Our aggregator for identifying commercial opportunities within the healthcare sector. By analyzing company profiles and market dynamics, it highlights suitable drugs and products to enhance existing pipelines and identifies potential mergers and acquisitions that align with your strategic goals. Embrace the future of your business with Motitus. Let's transform challenges into opportunities together! www.motitus.com https://lnkd.in/dxq4xQaz #Biotechnology #Pharmaceuticals #Healthtech #Motitus #Healthcare #Consulting #BusinessConsulting #Pharma #PharmaceuticaIndustry
To view or add a comment, sign in
-
🚀 How do we gear up our organisation to commercialise and scale, without losing our innovative core? Today, in the third module of our life science scaleup program #10xHealth, our expert Anna Brattström from Lund University School of Economics and Management guided our 10xHealth companies through frameworks and tools relating to organising people, processes and organisational structures that are foundational for growth, managing the tension between explorative and exploitative phases of a company’s journey, as well as the shift from a focus on science to a focus on business. 📈 The #10xHealth program is targeted towards life science companies with the ambition to grow and scale. It is jointly developed by SmiLe Venture Hub and Medicon Village and co-financed by the European Regional Development Fund. 🌟 Companies participating in the 2024 pilot include: Paindrainer AB, Iconovo AB, Neola Medical, Uman Sense, Cyxone, NanoEcho AB 📧 If you're curious to find out more, feel free to reach out to Christine Dahlman Jacobsen or Sarah Lidé. #lifescience #scalingup
To view or add a comment, sign in
-
🔍 Medtech at a Turning Point 🔍 TVM Capital Life Science’s Managing Partner, Dr. Luc Marengere, recently shared insights with Shani Alexander of BioWorld MedTech at LSI Europe '24 on the state of the medtech sector—medtech is indeed at a pivotal moment. 💬 "The entire ecosystem is coming together. It’s not just about technologies; you need investors and buyers creating a healthier, more viable industry. Now, we’re seeing companies valued at biotech levels and exciting opportunities for investment," says Luc. With over $900M under management, TVM is proud to support companies transforming patient care and medtech innovation. Notable investments, such as TVM’s support of Access Vascular, Inc. CSA Medical Inc, Kent Imaging and Vektor Medical, Inc. Medical reflect our commitment to fostering solutions that deliver tangible patient outcomes and redefine treatment pathways. As Luc notes, these are "truly transformational opportunities"—and the future is bright for medtech. Read the full article here (pay wall): https://lnkd.in/eWMrydRb #MedTech #HealthcareInnovation #VentureCapital #LifeSciences #MedTechDeals #InvestmentOpportunities
To view or add a comment, sign in
-
In a sea of talent, some gems stand out. From medical device wizards to biotech mavens, our seasoned executives are ready to take your startup from vision to victory. Let's bring breakthrough innovation together. ✨🚀 #ExecutiveTalent #HealthTech #BiotechBrilliance #StartupGrowth #ExecutiveSearch #LeadershipExcellence #MedTechInnovators #StrategicHiring #IndustryLeaders #CorporateVisionaries #biotechnology
To view or add a comment, sign in
-
Startups, early ventures and teams (including research teams) within precision/personalised medicine can now apply to two different calls developed by EIT Health within EP PerMed - the European Partnership for Personalised Medicine!
EP PerMed introduces two exciting opportunities for start-ups, researchers, and early-stage teams working on cutting-edge solutions in #PersonalisedMedicine. These programmes aim to accelerate the development, validation, and market readiness of transformative innovations that enhance patient care. 𝐅𝐚𝐬𝐭 𝐓𝐫𝐚𝐜𝐤 𝐕𝐚𝐥𝐢𝐝𝐚𝐭𝐢𝐨𝐧 𝐏𝐫𝐨𝐠𝐫𝐚𝐦𝐦𝐞 Designed to address a critical bottleneck in personalised medicine development, this programme supports validation studies to elevate projects to higher technological and market readiness levels. 𝐕𝐞𝐧𝐭𝐮𝐫𝐞 𝐂𝐫𝐞𝐚𝐭𝐢𝐨𝐧 𝐏𝐫𝐨𝐠𝐫𝐚𝐦𝐦𝐞 This programme empowers early-stage ventures or teams in personalised medicine by bridging the gap between innovation and commercialisation through mentoring, business model development, and customer discovery. 𝐒𝐮𝐛𝐦𝐢𝐬𝐬𝐢𝐨𝐧 𝐃𝐞𝐚𝐝𝐥𝐢𝐧𝐞𝐬: 13 March 2025. Read more: https://lnkd.in/duSH-qin
To view or add a comment, sign in
-
In a sea of talent, some gems stand out. From medical device wizards to biotech mavens, our seasoned executives are ready to take your startup from vision to victory. Let's bring breakthrough innovation together. ✨🚀 #ExecutiveTalent #HealthTech #BiotechBrilliance #StartupGrowth #ExecutiveSearch #LeadershipExcellence #MedTechInnovators #StrategicHiring #IndustryLeaders #CorporateVisionaries #biotechnology
To view or add a comment, sign in
-
Breaking the barriers to innovation, more expert insights from #SurgTech2024 In a revealing interview, healthcare expert, Graeme L. Smith, CEO of OstomyCure, shed light on the significant challenges posed by funding constraints and complex regulatory landscapes. According to Graeme, securing adequate funding and navigating the regulations are daunting tasks that can hinder a company to scale up or even move to a new phase like the sustainable product innovations. Overcoming funding and regulatory barriers by: - Proactively engaging with potential investors, including venture capitalists, angel investors, and strategic partners, can increase access to funding and expertise. - Developing a comprehensive regulatory strategy early in the innovation lifecycle, with expert guidance, can streamline approval processes and mitigate risks. - Leveraging accelerators and incubators. - Forming strategic partnerships with established MedTech companies, academic institutions, and regulatory bodies can facilitate knowledge sharing, resource pooling, and regulatory navigation. We talk in depth about how you can stay ahead of curve in your innovation journey in our “10 insights to innovation success” series which you can find here: https://lnkd.in/eSEK4XPH To learn more about overcoming funding and regulatory barriers in the MedTech industry and how Pd-m can assist your organization, schedule a meeting with our team by visiting https://lnkd.in/etRjUH4C. #adaptability #commercialisation #design #problemsolving #regulations #innovation #barriers #evidence #evaluation #strategy #solution ABHI Medilink North of England Bionow SBRI Healthcare Varaidzo (Vee) Mapunde Andrew Davidson Rich Shaw NIHR for Industry
To view or add a comment, sign in
2,472 followers
General Partner at Peregrine Ventures
2moThank you, Amit Talia Alfasi, for your professional assistance and for facilitating this opportunity. I look forward to expanding our collaboration with the exceptional medical team at Ichilov, as well as with Ichilov Tech, led by Benjamin Soffer and his talented team, including Asher Castiel, Tali Marienberg and Yael Arusi